English (UK)
中文版庆一 陈
成都新华海纳医疗创新股权投资中心（有限合伙）该支基金由新华瑞恒基金管理公司与雷宁博士等医疗领域专业投资团队共同发起。基金围绕创新医药、医疗器械、医疗服务领域中临床应用前景良好，市场空间巨大的早期企业，以及未来5年营业收入及净利润增长迅速，可能成为龙头企业或并购标的。其中，创新医药以早期大、小分子创新药物和海外引进创新药物为主要布局方向；医疗器械以天使轮/A轮微创外科和生物材料为重点关注对象；医疗服务领域将以高性能生物材料研发平台、医疗互联网平台和医疗人工智能平台为主。
新华海纳股权投资基金
投资总监聪 陈
Guangdong Fengle Group Co., Ltd. (hereinafter referred to as “Fengle Group”), established in 2004, is a diversified and comprehensive industrial group corporation integrated of industry, commerce and Finance.
Fengle Group focuses on energy, new energy, energy conservation and environmental protection, industrial investment and holding, and supply chain finance, optimizing strategic layout and business structure.
Fengle group joined new fields of urban renewal, rural revitalization, medical technology, modern agriculture and animal husbandry etc. while expanding its traditional businesses.
Fengle Group headquartered in Zengcheng district, Guangzhou, then set up five management headquarters in South China, North China, East China, Southwest and Northwest China, achieving nationalization of region and products.
Fengle Group operates in more than 10 countries and regions and creates an annual output value of more than 10 billion yuan.
Guangzhou Fengle Medical Technology Co., Ltd. was founded by the parent company Guangdong Fengle Group Co.,Ltd. The face mask plant of Fengle Medical covers an area of 15,000 square meters, equipped with automatic mask production equipment, automatic packaging equipment, inspection and testing equipment.
Fengle Medical has been established with fine industry, adhering to the philosophy of value discovery, innovation and enlightenment, dedication and altruism, people-oriented, harmony and honesty, cooperation and sharing, innovation and win-win. It provides customers with a full range of quality and value-added services to achieve customer satisfaction, company satisfaction, social satisfaction. Due to rigorous, scientific, efficient and reasonable management system, the company's operation is more standardized, that become a leader in the local industry, developing steadily, rapidly and efficiently.
At present, the company's main products are: Disposable protective masks, disposable children's masks, disposable medical masks, medical surgical masks, KN95 protective masks etc. All the products have obtained the full performance Inspection and Test Report, in line with the relevant national standards and requirements. The company has obtained the ISO 13485 quality system certification, obtained the European Union CE certification, the United States FDA listing for the record, and listed in the "China Chamber of Commerce for Import and Export of Medicines and Health Products Double White List".
Health care is a sunrise industry forever. Fengle Group will take Fengle Medical Technology Co., Ltd as the starting point to build a comprehensive and integrated medical health industry base in the region by connecting with Zhongguancun and the provincial venture capital medical devices, classification diagnosis and treatment, remote diagnosis, health, research and development, and venture capital big data resources.
Fengle Group focuses on energy, new energy, energy conservation and environmental protection, industrial investment and holding, and supply chain finance, optimizing strategic layout and business structure.
Fengle group joined new fields of urban renewal, rural revitalization, medical technology, modern agriculture and animal husbandry etc. while expanding its traditional businesses.
Fengle Group headquartered in Zengcheng district, Guangzhou, then set up five management headquarters in South China, North China, East China, Southwest and Northwest China, achieving nationalization of region and products.
Fengle Group operates in more than 10 countries and regions and creates an annual output value of more than 10 billion yuan.
Guangzhou Fengle Medical Technology Co., Ltd. was founded by the parent company Guangdong Fengle Group Co.,Ltd. The face mask plant of Fengle Medical covers an area of 15,000 square meters, equipped with automatic mask production equipment, automatic packaging equipment, inspection and testing equipment.
Fengle Medical has been established with fine industry, adhering to the philosophy of value discovery, innovation and enlightenment, dedication and altruism, people-oriented, harmony and honesty, cooperation and sharing, innovation and win-win. It provides customers with a full range of quality and value-added services to achieve customer satisfaction, company satisfaction, social satisfaction. Due to rigorous, scientific, efficient and reasonable management system, the company's operation is more standardized, that become a leader in the local industry, developing steadily, rapidly and efficiently.
At present, the company's main products are: Disposable protective masks, disposable children's masks, disposable medical masks, medical surgical masks, KN95 protective masks etc. All the products have obtained the full performance Inspection and Test Report, in line with the relevant national standards and requirements. The company has obtained the ISO 13485 quality system certification, obtained the European Union CE certification, the United States FDA listing for the record, and listed in the "China Chamber of Commerce for Import and Export of Medicines and Health Products Double White List".
Health care is a sunrise industry forever. Fengle Group will take Fengle Medical Technology Co., Ltd as the starting point to build a comprehensive and integrated medical health industry base in the region by connecting with Zhongguancun and the provincial venture capital medical devices, classification diagnosis and treatment, remote diagnosis, health, research and development, and venture capital big data resources.
Guangzhou Fengle Medical Technology Co., Ltd
投资总监佳 韩
南京融药创汇科技有限公司（以下简称“融药创汇”）是一家聚焦新医药与生命健康产业的创新型才智服务与科技服务公司，愿景是建设新医药行业领先的菁英网络与科创服务平台，旨在携手助力医药行业菁英成长创业，汇智赋能健康产业创新升级。
南京融药创汇科技有限公司
总经理世中 马
信立泰是一家集化学药、生物药、医疗器械于一体的医药上市公司，专注于心脑血管、糖尿病、肾病、骨科等领域，致力于满足未被满足的临床需求，为广大患者提供整体的创新解决方案。
Responsive Web Design powered by 